How Has CME’s Revenue And EBITDA Changed In The Last Five Years?
CME’s revenue grew $323 million over the last five years, largely driven by increased volumes due to volatility in the financial markets. On the other hand, operating expenses grew $175 million in the last five years, owing to higher compensation and benefits expenses. Consequently, the company’s EBITDA rose $148 million as higher costs were offset by the rise in revenues.
Relevant Articles
Have more questions about CME? See the links below:
- CME Group Sees Growth In All Asset Classes In February
- What’s CME’s Revenue And EBITDA Breakdown In Terms Of Operating Segments?
- How Has CME’s Revenue Composition Changed Over The Past 5 Years?
Notes:
1) The purpose of these analyses is to help readers focus on a few important things. We hope such lean communication sparks thinking, and encourages readers to comment / ask questions on the comments section
2) Figures mentioned are approximate values to help our readers remember the key concepts more intuitively. For precise figures, please refer to the full Trefis analysis for CME Group.
View Interactive Institutional Research (Powered by Trefis):
Global Large Cap | U.S. Mid & Small Cap | European Large & Mid Cap
More Trefis Research